Sensyne Health signs up Michael Macdonnell as new COO
Clinical artificial intelligence (AI) company Sensyne Health has appointed Michael Macdonnell to its senior management team, it announced on Thursday, as its chief operating officer.
The AIM-traded firm said Macdonnell would join Sensyne, with effect from 28 September.
He is currently director of global deployment at Google Health, which he joined from Google DeepMind.
Prior to joining Google, Macdonnell was national director of system transformation and director of strategy at NHS England, where he oversaw the delivery of key strategic initiatives including the NHS Five-Year Forward View, and the development of integrated care systems.
Previously, he had held roles at Accenture, the Centre for Health Policy, Imperial College London and as an advisor at the Prime Minister's Delivery Unit.
Sensyne said Macdonnell remained an honorary fellow at the Institute of Global Health Innovation, Imperial College London, and is a policy fellow at the Centre for Science and Policy, University of Cambridge.
“Michael brings deep healthcare expertise and a strong track-record of driving healthcare improvements through the application of advanced technology,” said chief executive officer Lord Drayson.
“His experience of applying artificial intelligence to real-world research and clinical practice, in collaboration with both NHS and US-based healthcare providers, will be crucial in helping Sensyne to grow to its next stage of development.
“Importantly, he also strongly values social purpose, which matches Sensyne's unique business model and ethical approach to the use of clinical AI.”
At 1555 BST, shares in Sensyne Health were down 3.4% at 71p.